Literature DB >> 18793760

The propensity for deamidation and transamidation of peptides by transglutaminase 2 is dependent on substrate affinity and reaction conditions.

Jorunn Stamnaes1, Burkhard Fleckenstein, Ludvig M Sollid.   

Abstract

Transglutaminase 2 (TG2) catalyzes cross-linking or deamidation of glutamine residues in peptides and proteins. The in vivo deamidation of gliadin peptides plays an important role in the immunopathogenesis of celiac disease (CD). Although deamidation is considered to be a side-reaction occurring in the absence of suitable amines or at a low pH, a recent paper reported the selective deamidation of the small heat shock protein 20 (Hsp20), suggesting that deamidation could be a substrate dependent event. Here we have measured peptide deamidation and transamidation in the same reaction to reveal factors that affect the relative propensity for the two possible products. We report that the propensity for deamidation by TG2 is both substrate dependent and influenced by the reaction conditions. Direct deamidation is favored for poor substrates and at low concentrations of active TG2, while indirect deamidation (i.e. hydrolysis of transamidated product) can significantly contribute to the deamidation of good peptide substrates at higher enzyme concentrations. Further, we report for the first time that TG2 can hydrolyze iso-peptide bonds between two peptide substrates. This was observed also for gliadin peptides introducing a novel route for the generation of deamidated T cell epitopes in celiac disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18793760      PMCID: PMC2626647          DOI: 10.1016/j.bbapap.2008.08.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  25 in total

Review 1.  Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases.

Authors:  D Aeschlimann; V Thomazy
Journal:  Connect Tissue Res       Date:  2000       Impact factor: 3.417

2.  T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.

Authors:  O Molberg; S McAdam; K E Lundin; C Kristiansen; H Arentz-Hansen; K Kett; L M Sollid
Journal:  Eur J Immunol       Date:  2001-05       Impact factor: 5.532

3.  Ligand-induced conformational changes in tissue transglutaminase: Monte Carlo analysis of small-angle scattering data.

Authors:  P Mariani; F Carsughi; F Spinozzi; S Romanzetti; G Meier; R Casadio; C M Bergamini
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

4.  High selectivity of human tissue transglutaminase for immunoactive gliadin peptides: implications for celiac sprue.

Authors:  Justin L Piper; Gary M Gray; Chaitan Khosla
Journal:  Biochemistry       Date:  2002-01-08       Impact factor: 3.162

Review 5.  Transglutaminase 2: an enigmatic enzyme with diverse functions.

Authors:  Laszlo Fesus; Mauro Piacentini
Journal:  Trends Biochem Sci       Date:  2002-10       Impact factor: 13.807

6.  Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process.

Authors:  Burkhard Fleckenstein; Øyvind Molberg; Shuo-Wang Qiao; Dietmar G Schmid; Florian von der Mülbe; Katja Elgstøen; Günther Jung; Ludvig M Sollid
Journal:  J Biol Chem       Date:  2002-07-01       Impact factor: 5.157

7.  Structural basis for gluten intolerance in celiac sprue.

Authors:  Lu Shan; Øyvind Molberg; Isabelle Parrot; Felix Hausch; Ferda Filiz; Gary M Gray; Ludvig M Sollid; Chaitan Khosla
Journal:  Science       Date:  2002-09-27       Impact factor: 47.728

8.  Specificity of tissue transglutaminase explains cereal toxicity in celiac disease.

Authors:  L Willemijn Vader; Arnoud de Ru; Yvonne van der Wal; Yvonne M C Kooy; Willemien Benckhuijsen; M Luisa Mearin; Jan Wouter Drijfhout; Peter van Veelen; Frits Koning
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

9.  Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury.

Authors:  Matthew Siegel; Pavel Strnad; R Edward Watts; Kihang Choi; Bana Jabri; M Bishr Omary; Chaitan Khosla
Journal:  PLoS One       Date:  2008-03-26       Impact factor: 3.240

10.  The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.

Authors:  H Arentz-Hansen; R Körner; O Molberg; H Quarsten; W Vader; Y M Kooy; K E Lundin; F Koning; P Roepstorff; L M Sollid; S N McAdam
Journal:  J Exp Med       Date:  2000-02-21       Impact factor: 14.307

View more
  28 in total

Review 1.  γ-Glutamylamines and neurodegenerative diseases.

Authors:  Thomas M Jeitner; Kevin Battaile; Arthur J L Cooper
Journal:  Amino Acids       Date:  2012-03-10       Impact factor: 3.520

Review 2.  Transglutaminase 2: a molecular Swiss army knife.

Authors:  Soner Gundemir; Gozde Colak; Janusz Tucholski; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2011-10-10

Review 3.  Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.

Authors:  Stefania Martucciello; Gaetana Paolella; Carla Esposito; Marilena Lepretti; Ivana Caputo
Journal:  Cell Mol Life Sci       Date:  2018-08-22       Impact factor: 9.261

Review 4.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

5.  The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes.

Authors:  Siri Dørum; Magnus Ø Arntzen; Shuo-Wang Qiao; Anders Holm; Christian J Koehler; Bernd Thiede; Ludvig M Sollid; Burkhard Fleckenstein
Journal:  PLoS One       Date:  2010-11-19       Impact factor: 3.240

6.  Aberrant calcium signaling by transglutaminase-mediated posttranslational modification of inositol 1,4,5-trisphosphate receptors.

Authors:  Kozo Hamada; Akiko Terauchi; Kyoko Nakamura; Takayasu Higo; Nobuyuki Nukina; Nagisa Matsumoto; Chihiro Hisatsune; Takeshi Nakamura; Katsuhiko Mikoshiba
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-08       Impact factor: 11.205

7.  The proinflammatory protein HMGB1 is a substrate of transglutaminase-2 and forms high-molecular weight complexes with autoantigens.

Authors:  William L Willis; Linan Wang; Takuma Tsuzuki Wada; Mark Gardner; Omar Abdouni; Jeffrey Hampton; Giancarlo Valiente; Nicholas Young; Stacy Ardoin; Sudha Agarwal; Michael A Freitas; Lai-Chu Wu; Wael N Jarjour
Journal:  J Biol Chem       Date:  2018-04-04       Impact factor: 5.157

8.  Modulation of transglutaminase 2 activity in H9c2 cells by PKC and PKA signalling: a role for transglutaminase 2 in cytoprotection.

Authors:  Ibtesam Almami; John M Dickenson; Alan J Hargreaves; Philip L R Bonner
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

9.  Antibodies against neo-epitope of microbial and human transglutaminase complexes as biomarkers of childhood celiac disease.

Authors:  D Agardh; T Matthias; P Wusterhausen; S Neidhöfer; A Heller; A Lerner
Journal:  Clin Exp Immunol       Date:  2019-11-11       Impact factor: 4.330

10.  Igs as Substrates for Transglutaminase 2: Implications for Autoantibody Production in Celiac Disease.

Authors:  Rasmus Iversen; M Fleur du Pré; Roberto Di Niro; Ludvig M Sollid
Journal:  J Immunol       Date:  2015-10-26       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.